Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Inspiration Healthcare Group EV-to-EBITDA?
Inspiration Healthcare GroupLSE:IHC 49 EV-to-EBITDA is 15.25 as of Aug. 13, 2026, which is 29% above its 10-year median of 11.82. GuruFocus rates LSE:IHC with a GF Score™ of 49/100 and a GF Value™ of £0.22 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 514 Medical Devices & Instruments companies, Inspiration Healthcare Group ranks worse than 51.95% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Inspiration Healthcare Group's enterprise value is £27.18 Mil.
Inspiration Healthcare Group's EBITDA for the trailing twelve months (TTM) ended in Jan. 2026 was £1.78 Mil. Therefore, Inspiration Healthcare Group's EV-to-EBITDA for today is 15.25.
The historical rank and industry rank for Inspiration Healthcare Group's EV-to-EBITDA or its related term are showing as below:
LSE:IHC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -15.7 Med: 11.82 Max: 57.56
Current: 15.25
During the past 13 years, the highest EV-to-EBITDA of Inspiration Healthcare Group was 57.56. The lowest was -15.70. And the median was 11.82.
LSE:IHC's EV-to-EBITDA is ranked worse than 51.95% of 514
companies
in the Medical Devices & Instruments industry
Industry Median: 14.825
vs LSE:IHC: 15.25
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Inspiration Healthcare Group (LSE:IHC) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Inspiration Healthcare Group's PE Ratio (TTM) for today is calculated as:
Inspiration Healthcare Group's share price for today is £0.185.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Inspiration Healthcare Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2026 was £-0.012.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Inspiration Healthcare Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inspiration Healthcare Group EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Inspiration Healthcare Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Inspiration Healthcare Group's EV-to-EBITDA falls into.
Inspiration Healthcare Group's current Enterprise Value is £27.18 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Inspiration Healthcare Group's EBITDA for the trailing twelve months (TTM) ended in Jan. 2026 was £1.78 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inspiration Healthcare Group (LSE:IHC) has a EV-to-EBITDA of 15.25 as of Aug. 13, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Inspiration Healthcare Group. This is 29% above median its historical median of 11.82. According to the industry distribution chart, Inspiration Healthcare Group ranks #267 out of 514 companies in the Medical Devices & Instruments industry, placing it in the top 51.9%.
Is Inspiration Healthcare Group's EV-to-EBITDA too high?
Inspiration Healthcare Group's current EV-to-EBITDA of 15.25 is 29% above median its 10-year median of 11.82. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.83. Inspiration Healthcare Group's value of 15.25 is 2.9% above this industry median. Based on the distribution chart, Inspiration Healthcare Group ranks #267 out of 514 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Inspiration Healthcare Group has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Inspiration Healthcare Group's EV-to-EBITDA compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Inspiration Healthcare Group ranks #267 out of 514 companies for EV-to-EBITDA. This places Inspiration Healthcare Group in the lower half of its industry. The industry median EV-to-EBITDA is 14.83. Inspiration Healthcare Group's value of 15.25 is 2.9% above this benchmark. While the company's 10-year median is 11.82 vs. the industry median of 14.83, Inspiration Healthcare Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.83, based on 514 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inspiration Healthcare Group's current EV-to-EBITDA of 15.25 is 2.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Inspiration Healthcare Group. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inspiration Healthcare Group's current EV-to-EBITDA is 15.25, which is 29% above median its own 10-year median of 11.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspiration Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, Inspiration Healthcare Group (LSE:IHC) is currently considered Modestly Undervalued. The stock's GF Value™ is £0.22, compared to a current price of £0.19 — trading 15.9% below its estimated fair value. The current EV-to-EBITDA is 15.25, which is 29% above median its 10-year median of 11.82 and 2.9% above the Medical Devices & Instruments industry median of 14.83. Inspiration Healthcare Group's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Inspiration Healthcare Group (LSE:IHC), the current EV-to-EBITDA is 15.25 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inspiration Healthcare Group (LSE:IHC) Overvalued in 2026?
Based on GuruFocus' analysis, Inspiration Healthcare Group stock appears to be undervalued.
The current stock price of £0.19 is trading 15.9% below its estimated GF Value™ of £0.22.
GuruFocus considers Inspiration Healthcare Group to be Modestly Undervalued.
Key valuation signals for LSE:IHC:
EV-to-EBITDA: 15.25 (29% above median its 10-year median of 11.82)
GF Value™: £0.22 vs. price of £0.19 (15.9% below fair value)
Industry Position: 2.9% above the Medical Devices & Instruments median (#267 of 514)
No single metric tells the full story. See the LSE:IHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inspiration Healthcare Group PLC supplies outcome-improving medical devices in the areas of neonatal intensive care and patient warming. It operates in the Critical Care Medical Devices segment which includes Critical Care, Operating Theatre, and Home Healthcare. The company derives the maximum of its revenue from the United Kingdom through the Critical Care market division.
49GF Score
Get the complete analysis for LSE:IHC
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:IHC has been successfully added to your 
